Clinical Trial Update: Comparing Number of Injection Sites of In-office Intravesical Onabotulinumtoxin A Treatments for Overactive Bladder: A Randomized Controlled Trial [Phase 4]

View source ↗

Summary

Phase 4 randomized trial comparing number of injection sites for in-office intravesical onabotulinumtoxinA in overactive bladder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Overactive Bladder

Drugs mentioned

• OnabotulinumtoxinA (botulinum toxin type A)

Snippet

Sponsor: Augusta University | Conditions: Overactive Bladder Syndrome, Overactive Bladder | Phase 4 | Status: UNKNOWN